CRT 2026

INNOVATIONS IN 2026

Moderator(s)

• 

  Steven R. Bailey, MD, MSCAI

  Professor of Medicine
  LSU Health Shreveport
  San Antonio, Texas, United States

  Disclosure information not submitted.
• 

  Howard C. Herrmann, MD, FACC, MSCAI

  John Bryfogle Professor Emeritus of Cardiovascular Medicine
  Perelman School of Medicine at the University of Pennsylvania
  Philadelphia, Pennsylvania, United States

  Disclosure(s): Affluent Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Artedrone: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Caranx: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Mass Medical Society: Editorial Fees (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MicroInterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)
• 

  Stanton J. Rowe, PhD

  CEO
  Nidus Biomedical
  Irvine, California, United States

  Disclosure(s): No financial relationships to disclose